These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 6496515
1. Appropriateness of sampling times for therapeutic drug monitoring. Mason GD, Winter ME. Am J Hosp Pharm; 1984 Sep; 41(9):1796-801. PubMed ID: 6496515 [Abstract] [Full Text] [Related]
2. Choosing optimal sampling times for therapeutic drug monitoring. Schumacher GE. Clin Pharm; 1985 Sep; 4(1):84-92. PubMed ID: 3971691 [Abstract] [Full Text] [Related]
3. Pitfalls and errors in drug monitoring: pharmacokinetic aspects. Ritschel WA. Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):559-66. PubMed ID: 6664156 [Abstract] [Full Text] [Related]
4. Appropriateness of therapeutic drug monitoring for lithium. Ratanajamit C, Soorapan S, Doang-ngern T, Waenwaisart W, Suwanchavalit L, Suwansiri S, Jantasaro S, Yanate I. J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880 [Abstract] [Full Text] [Related]
5. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients. Mann HJ, Wittbrodt ET, Baghaie AA, Cerra FB. Pharmacotherapy; 1998 Nov; 18(2):371-8. PubMed ID: 9545157 [Abstract] [Full Text] [Related]
7. Pharmacokinetic comparison of the one-point method with other methods in predicting steady state drug concentrations in multiple dosing. Ritschel WA, Erni W. Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):279-87. PubMed ID: 881281 [Abstract] [Full Text] [Related]
8. Digoxin therapeutic drug monitoring: an audit and review. Sidwell A, Barclay M, Begg E, Moore G. N Z Med J; 2003 Dec 12; 116(1187):U708. PubMed ID: 14752536 [Abstract] [Full Text] [Related]
9. Using pharmacokinetics in drug therapy. VI: Comparing methods for dealing with nonlinear drugs like phenytoin. Schumacher GE. Am J Hosp Pharm; 1980 Jan 12; 37(1):128-32. PubMed ID: 7361770 [Abstract] [Full Text] [Related]
10. Therapeutic drug monitoring: a survey of sub- and supra-therapeutic serum drug levels in a large teaching hospital. Frewin DB, Shaw DR, Bochner F. N Z Med J; 1982 Nov 10; 95(719):774-6. PubMed ID: 6959037 [Abstract] [Full Text] [Related]
13. Serum drug concentrations in clinical perspective. Koch-Weser J. Ther Drug Monit; 1981 Nov 10; 3(1):3-16. PubMed ID: 7015580 [Abstract] [Full Text] [Related]
15. Appropriateness of the use of serum digoxin and digitoxin assays. Slaughter RL, Schneider PJ, Visconti JA. Am J Hosp Pharm; 1978 Nov 10; 35(11):1376-9. PubMed ID: 707506 [Abstract] [Full Text] [Related]
16. Primer on clinical pharmacokinetics. Bauer LA. Am J Hosp Pharm; 1983 Oct 10; 40(10):1637-41. PubMed ID: 6638025 [Abstract] [Full Text] [Related]
18. Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models. Vrijens B, Tousset E, Rode R, Bertz R, Mayer S, Urquhart J. J Clin Pharmacol; 2005 Apr 10; 45(4):461-7. PubMed ID: 15778427 [Abstract] [Full Text] [Related]
19. Facilitating pharmacokinetic studies in children: a new use of dried blood spots. Patel P, Mulla H, Tanna S, Pandya H. Arch Dis Child; 2010 Jun 10; 95(6):484-7. PubMed ID: 20501544 [Abstract] [Full Text] [Related]
20. The impact of the site of blood sampling on pharmacokinetic parameters following sublingual dosing to dogs. Sohlberg E, Halldin MM, Annas A, Königsson K, Jansson B, Pehrson R, Borg N. J Pharmacol Toxicol Methods; 2013 Jun 10; 67(1):1-4. PubMed ID: 23138149 [Abstract] [Full Text] [Related] Page: [Next] [New Search]